Two-Drug Dolutegravir-Based Antiretroviral Therapy Associated With High Rates Of Virologic Suppression Among Patients With HIV Infection, Study Finds

Infectious Disease Advisor (6/12, Nye) reports, “Two-drug dolutegravir-based antiretroviral therapy was associated with high rates of virologic suppression among patients with HIV infection in real-world settings.” Additionally, “the selection of DTG-based ART by treating clinicians is primarily driven by a desire to avoid long-term toxicities. These study results were published in Infectious Diseases and Therapy.”